Correlation Between Bristol Myers and HEXPOL AB

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and HEXPOL AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and HEXPOL AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and HEXPOL AB, you can compare the effects of market volatilities on Bristol Myers and HEXPOL AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of HEXPOL AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and HEXPOL AB.

Diversification Opportunities for Bristol Myers and HEXPOL AB

-0.71

Correlation Coefficient

Bristol Myers  HEXPOL AB

Pay attention - limited upside

The 3 months correlation between Bristol and HEXPOL is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and HEXPOL AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HEXPOL AB and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with HEXPOL AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HEXPOL AB has no effect on the direction of Bristol Myers i.e., Bristol Myers and HEXPOL AB go up and down completely randomly.

Pair Corralation between Bristol Myers and HEXPOL AB

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 1.66 times more return on investment than HEXPOL AB. However, Bristol Myers is 1.66 times more volatile than HEXPOL AB. It trades about 0.04 of its potential returns per unit of risk. HEXPOL AB is currently generating about -0.02 per unit of risk. If you would invest  86,229  in Bristol Myers Squibb on September 28, 2024 and sell it today you would earn a total of  13,660  from holding Bristol Myers Squibb or generate 15.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	96.24%
Values	Daily Returns

Bristol Myers Squibb  vs.  HEXPOL AB

Bristol Myers Squibb

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol Myers reported solid returns over the last few months and may actually be approaching a breakup point.

HEXPOL AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HEXPOL AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's essential indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Bristol Myers and HEXPOL AB

The main advantage of trading using opposite Bristol Myers and HEXPOL AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, HEXPOL AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HEXPOL AB will offset losses from the drop in HEXPOL AB's long position.

The idea behind Bristol Myers Squibb and HEXPOL AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.